Advertisement

Secukinumab in AxSpA and PsA: A Drug Survival Analysis

A new retrospective study to be presented at the American College of Rheumatology/Empowering Rheumatology Professionals Annual Meeting assessed drug survival of secukinumab and associated...

Etanercept Treatment Yields Meaningful Radiographic Outcomes in RA and PsA

Past research has established clinical effectiveness of etanercept in the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but its impact on radiographic...

Patient-reported and Ultrasound Outcomes in PsO and PsA

Patient-reported outcomes (PROs) are significant in patients with psoriatic arthritis (PsA), and while they frequently shed light on disease activity, impact of disease, quality...

Tildrakizumab Is Safe in Active PsA

A study that will be presented at the American College of Rheumatology/Empowering Rheumatology Professionals Annual Meeting evaluated safety outcomes in patients with active psoriatic...
Advertisement